Pfizer ($PFE) CEO Ian Read (photo) told the Financial Times that he hopes to divest the company's animal health and nutrition units by June 13, gaining cash to finance new bolt-on acquisitions and return money to shareholders. Report
The biopharmaceutical industry's largest companies have grown too large to offer shareholders a compelling return. L.E.K.'s analysis shows how pharma companies can address their most pressing challenges. Learn more
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 90,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!